SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-23-000054
Filing Date
2023-10-10
Accepted
2023-10-10 08:56:28
Documents
15
Period of Report
2023-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20231004x8k.htm   iXBRL 8-K 33277
2 EX-10.1 ibio-20231004xex10d1.htm EX-10.1 47074
  Complete submission text file 0001420720-23-000054.txt   300511

Data Files

Seq Description Document Type Size
3 EX-101.SCH ibio-20231004.xsd EX-101.SCH 4189
4 EX-101.DEF ibio-20231004_def.xml EX-101.DEF 3263
5 EX-101.LAB ibio-20231004_lab.xml EX-101.LAB 679
6 EX-101.PRE ibio-20231004_pre.xml EX-101.PRE 10598
9 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20231004x8k_htm.xml XML 4621
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 231315910
SIC: 2834 Pharmaceutical Preparations